Quiz of the week – January 30 to February 3

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Quiz of the week – January 30 to February 3

Test your knowledge of the week’s IP news in Managing IP’s new weekly quiz

1. Which company became the fourth brand owner to declare its intention to apply for a generic top-level domain this week?

2. In the Specsavers v Asda case, the Court of Appeal in London has referred questions to the Court of Justice of the EU regarding colour trade marks. Which colour did the case concern?

3. Which country may be about to approve a law that could impose sentences of up to 12 years for cybersquatting?

4. Authors’ royalties collected in 2010 increased by 5.5% according to CISAC. How much was collected?

5. Who resigned over ACTA this week?

Answers will be available on managingip.com next Friday February 10.

Answers to last week’s quiz:

1. 23

2. Red

3. Dot-xxx

4. Eastern District of Virginia

5. Germany and China

more from across site and SHARED ros bottom lb

More from across our site

The team, comprising two partners and one senior consultant, plans to offer “highly differentiated” services to clients
HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Gift this article